Clean Science IPO
(i) Clean Science and Technology Limited is among the few companies globally-focused entirely on developing newer technologies using in-house catalytic processes, which are eco-friendly and cost-competitive. It manufactures functionally critical specialty chemicals such as Performance Chemicals (i.e. MEHQ, BHA, and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals (i.e. 4-MAP and Anisole).
Raw materials used for producing above chemicals are phenol, hydrogen peroxide, acetic anhydride, tertiary butyl alcohol, acetone, methanol, and cyclohexylamine. Out of total raw material 7% is imported . Most of the raw material are derivatives of crude oil. Source from India, China and US.
(ii) Within 17 years of incorporation, the company has grown to be the largest manufacturer globally of MEHQ, BHA, Anisole, and 4-MAP, in terms of manufacturing capacities as of 2020.
(iii) Its customers include manufacturers and distributors in India as well as other regulated international markets including China, Europe, the United States of America, Taiwan, Korea, and Japan.
(iv) It has two certified production facilities in India strategically located at Kurkumbh (Maharashtra). It is also in the process of setting up a third facility adjacent to its existing facilities at Kurkumbh (Maharashtra), and in also discussion with the authorities for acquiring land for the fourth facility.
(i) Experienced Promoters and senior management
(ii) Strong and long-standing relationships with key customers
(iii) Automated manufacturing facilities.
Objects of the Clean Science IPO:
Clean Science IPO Details:
|Open Date:||Jul 07 2021|
|Close Date:||Jul 09 2021|
|Face Value:||₹ 1 Per Equity Share|
|Issue Type:||Book Building|
|Issue Size:||1546 Cr.|
|Lot Size:||16 Shares|
|Issue Price:||₹ 880 - 900 Per Equity Share|
|Listing Date:||Jul 19 2021|
Promoters And Management:
Financials of Clean Science IPO:
|Particulars (in Million)||Mar-21||Mar-20||Mar-19|
|Cost of materials consumed||1378||1279||1786|
|Changes in inventories||-142||12||-73|
|Employee benefits expenses||435||310||248|
|Profit before tax||2673||1823||1365|
|Total tax expenses||689||426||388|
|Profit After tax||1983||1396||976|
Comparison With Peers:
|Peer||Sales||3-year Revenue Growth||3-year PAT Growth||OPM (FY21)||D/E||ROE (FY21)||ROCE(FY21)||Receivables days||P/E|
|PI Industries Limited||4577||27%||34%||22%||0.05x||19%||22%||56||60|
|Camlin Fine Sciences Limited||1187||15.36%||614%||16%||0.92x||9%||14%||83||49|
|Navin Flourine International Limited||1179||8.80%||31.59%||26%||0||16%||22%||88||75|
|Fine Organic Industries Limited||1133||3.39%||-6.07%||18%||0.08x||16%||22%||52||73|
|Vinati Organics Limited||954||-8.04%||-2.33%||37%||0||17.40%||24%||106||77|